L

Ligand Pharmaceuticals
D

LGND

114.800
USD
1.05
(0.92%)
Market Closed
Volume
0
EPS
5
Div Yield
-
P/E
46
Market Cap
2,169,188,820
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    A
    AGIO
    -0.380
    (-1.06%)
    35.390 USD
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    I
    INCY
    1.910
    (2.85%)
    68.910 USD
    J
    JAZZ
    0.140
    (0.11%)
    122.970 USD
    N
    NBIX
    0.490
    (0.36%)
    135.460 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Ligand Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.